Compare NSRX & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSRX | LOAN |
|---|---|---|
| Founded | 2019 | 1989 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.4M | 51.9M |
| IPO Year | 2025 | 1999 |
| Metric | NSRX | LOAN |
|---|---|---|
| Price | $5.50 | $4.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $20.50 | N/A |
| AVG Volume (30 Days) | 4.8K | ★ 30.0K |
| Earning Date | 03-20-2026 | 03-11-2026 |
| Dividend Yield | N/A | ★ 10.22% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.46 |
| Revenue | N/A | ★ $7,138,128.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.47 |
| P/E Ratio | ★ N/A | $9.72 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.42 | $4.29 |
| 52 Week High | $9.99 | $6.05 |
| Indicator | NSRX | LOAN |
|---|---|---|
| Relative Strength Index (RSI) | 36.47 | 40.12 |
| Support Level | $5.42 | $4.45 |
| Resistance Level | $5.85 | $4.59 |
| Average True Range (ATR) | 0.28 | 0.12 |
| MACD | -0.13 | 0.00 |
| Stochastic Oscillator | 3.51 | 16.88 |
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.